Ovarian cancer screening: Difference between revisions
Jump to navigation
Jump to search
Mahshid |
Hudakarman (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
Please help WikiDoc by adding content here. It's easy! Click [[Help:How to Edit a Page|here]] to learn about editing. | Please help WikiDoc by adding content here. It's easy! Click [[Help:How to Edit a Page|here]] to learn about editing. | ||
*There are no recommendations for screening ovarian cancer in asymptomatic women although bestter outcome associated with early diagnosis<ref name="pmid27284942">{{cite journal| author=Galea M, Gauci G, Calleja-Agius J, Schembri-Wismayer P| title=Peritoneal biomarkers in the early detection of ovarian cancer. | journal=Minerva Ginecol | year= 2017 | volume= 69 | issue= 1 | pages= 84-99 | pmid=27284942 | doi=10.23736/S0026-4784.16.03943-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27284942 }} </ref> | |||
== References == | == References == |
Revision as of 15:27, 12 July 2019
Ovarian cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian cancer screening On the Web |
American Roentgen Ray Society Images of Ovarian cancer screening |
Risk calculators and risk factors for Ovarian cancer screening |
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
- There are no recommendations for screening ovarian cancer in asymptomatic women although bestter outcome associated with early diagnosis[1]
References
- ↑ Galea M, Gauci G, Calleja-Agius J, Schembri-Wismayer P (2017). "Peritoneal biomarkers in the early detection of ovarian cancer". Minerva Ginecol. 69 (1): 84–99. doi:10.23736/S0026-4784.16.03943-5. PMID 27284942.